Most of the known approved drugs comprise functionalized heterocyclic compounds as subunits. Among them, non-fluorescent quinazolines with four different substitution patterns are found in a variety of clinically used pharmaceuticals, while 4,5,7,8-substituted quinazolines and those displaying their own specific fluorescence, favourable for cellular uptake visualization, have not been described so far. Here we report the development of a one-pot synthetic strategy to access these 4,5,7,8-substituted quinazolines, which are fluorescent and feature strong antiviral properties (EC50 down to 0.6±0.1 μM) against human cytomegalovirus (HCMV). Merging multistep domino processes in one-pot under fully metal-free conditions leads to sustainable, maximum efficient and high-yielding organic synthesis. Furthermore, generation of artesunic acid–quinazoline hybrids and their application against HCMV (EC50 down to 0.1±0.0 μM) is demonstrated. Fluorescence of new antiviral hybrids and quinazolines has potential applications in molecular imaging in drug development and mechanistic studies, avoiding requirement of linkage to external fluorescent markers.
Air and visible light have been used in facile direct C−H oxidation of cyclic tertiary amines at ambient conditions, employing organic dyes as photocatalysts and LED. Tolerance of this new environmentally compatible protocol to various side‐chain derivatizations of tryptoline and tetrahydroisoquinoline substrates was demonstrated. The developed method provides a straightforward and sustainable route towards δ‐lactams, which feature strong antiviral properties (EC50 down to 4.6±1.8 μm) against human cytomegalovirus (HCMV). The clear advantages, which are easily available and inexpensive reagents, organic dyes, visible light, air/O2 and atom efficiency, make this system highly appealing for synthesis of versatile Strychnocarpine alkaloid derivatives with antiviral activity.
Substituted
2,6-dicyanoanilines are versatile electron donor–acceptor
compounds, which have recently received considerable attention, since
they exhibit strong fluorescence and may have utility in the synthesis
of fluorescent materials, non-natural photosynthetic systems, and
materials with nonlinear optical properties. The majority of known
synthetic procedures are, however, “stop-and-go” reaction
processes involving time-consuming and waste-producing isolation and
purification of product intermediates. Here, we present the synthesis
of substituted 2,6-dicyanoanilines via atom-economical and eco-friendly
one-pot processes, involving metal-free domino reactions, and their
subsequent photochemical and photophysical measurements and theoretical
calculations. These studies exhibit the existence of an easily tunable
radical ion pair-based charge-transfer (CT) emission in the synthesized
2,6-dicyanoaniline-based electron donor–acceptor systems. The
charge-transfer processes were explored by photochemical and radiation
chemical measurements, in particular, based on femtosecond laser photolysis
transient absorption spectroscopy and time-resolved emission spectroscopy,
accompanied by pulse radiolysis and complemented by quantum chemical
investigations employing time-dependent density-functional theory.
This chromophore class exhibits a broad-wavelength-range fine-tunable
charge recombination emission with high photoluminescence quantum
yields up to 0.98. Together with its rather simple and cost-effective
synthesis (using easily available starting materials) and customizable
properties, it renders this class of compounds feasible candidates
as potential dyes for future optoelectronic devices like organic light-emitting
diodes (OLEDs).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.